Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.

Foldax has revealed one-year outcomes from the India Clinical Trial of the TRIA mitral valve. Presented at the Cardiovascular ...

What researchers did observe by year's end, in terms of clinical events in the 67 patients with symptomatic ...

The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

Foldax announces late-breaking, one-year data on the TRIA Mitral Valve at New York Valves 2025, which was concurrently ...

Mitral valve prolapse (MVP) is a common heart condition that rarely causes serious health problems. It develops when a lax valve in the heart doesn't close properly, causing blood to leak backward ...

The MyClip TEER System enables precise closure of the mitral valve flaps, effectively preventing the backwards flow of ...

Foldax® Inc., a leader in the development of innovative polymer heart valves, today announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good ...

Five patients here have undergone the new treatment since February 2025. Read more at straitstimes.com. Read more at ...

Background: Mitral annular calcification has been associated with various systemic and cardiac diseases, with a higher prevalence in women and patients over 70. A possible association between mitral ...